Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
96 participants
OBSERVATIONAL
2013-06-30
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Funding Source - Nestec Ltd.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-invasive Optical Detection of Iron Deficiency in Children
NCT02701309
Non-invasive Diagnostics of Iron Deficiency in Surgical Patients by Measuring Zinc Protoporphyrin-IX
NCT03071497
Diagnostic of Iron Deficiency by Means of Non Invasive Measurement of Zink Protoporphyrin IX
NCT03231865
IRON DEFICIENCY ANEMIA IN RELATION TO PINCH STRENGTH AND HAND DEXTERITY IN PRESCHOOL CHILDREN
NCT05959122
Clinical and Laboratory Investigation of Humans With Informative Iron or Erythroid Phenotypes
NCT00102245
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study could help to establish the non-invasive fluorescence measurement of zinc protoporphyrin-IX as a rapid, easy to use means for point-of-care screening for iron deficiency in resource-limited settings lacking laboratory infrastructure.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Not an interventional study
Not an interventional study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pregnancy and delivery without study-relevant complications
* Hb value pre-partum greater or equal 12 g/dL or less or equal 11 g/dL
* Regular blood withdrawal before and after delivery for clinical indications
* Informed consent to participation in the study
* Age 18 or older
Exclusion Criteria
* Transfusion of blood products in the course of delivery
* Thalassemia and sickle cell anemia
* Any acute or chronic infectious or inflammatory disease
* Insufficient amount of residual blood in the clinically indicated post partum sample
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Klinikum der Universitaet Muenchen, Grosshadern
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Uwe Hasbargen
PD Dr. med.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Uwe Hasbargen, PD Dr. med.
Role: PRINCIPAL_INVESTIGATOR
LMU Klinikum
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Obstetrics and Gynecology, Klinikum der Universitaet Muenchen, Grosshadern
Munich, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LFL_01/2012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.